Skip to content

Insider · CIK 0001950021

Roy Galvin

presidentofficer

Files at HAE (HAEMONETICS CORP). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 31, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-145$50.01$7,25112,811Nov 3, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+5,689--12,932Jun 13, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+12,317$0.00$012,317Jun 13, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+6,755--13,998May 20, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+14,626$0.00$014,626May 20, 2025
May 15, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-201$69.38$14k7,500May 19, 2025
May 16, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-257$70.31$18k7,243May 19, 2025
Nov 1, 2024HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-161$71.48$12k7,373Nov 5, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Roy Galvin: insider trades and track record | InsiderTell